Professional Documents
Culture Documents
Key words: microencapsulation, natural identical flavor, organic acid, slow-release, swine
2007 American Society of Animal Science. All rights reserved.
INTRODUCTION
486
487
CTRL
PB
NPB
%, as-fed basis
Ingredient
Corn
Barley
Flaked barley
Soybean oil
Sweet dried whey
Wheat bran
Soybean meal (44%)
Potato protein2
Limestone CaCO3
Calcium sulphate (CaSO4)
Monocalcium phosphate (Ca(H2PO4)2)
Sodium chloride (NaCl)
DL-Methionine
L-Lysine HCl
L-Threonine
L-Tryptophan
Vitamin/mineral premix3
Micro-encapsulated blend
Nonmicroencapsulated blend
25.4
10.5
20.7
3.5
5.0
10.2
17.0
3.5
0.4
0.6
1.6
0.30
0.16
0.4
0.16
0.04
0.5
25.4
10.5
20.7
3.5
5.0
9.8
17.0
3.5
0.4
0.6
1.6
0.30
0.16
0.4
0.16
0.04
0.5
0.4
25.4
10.5
20.7
3.5
5.0
9.8
17.0
3.5
0.4
0.6
1.6
0.30
0.16
0.4
0.16
0.04
0.5
0.4
Chemical composition, % of DM
DM, %
CP
Ether extract
Crude fiber
Ash
Starch
90.86
19.30
6.74
5.01
6.84
39.61
90.86
19.08
6.76
4.96
6.61
37.99
90.96
19.16
7.02
4.97
6.62
37.95
16.07
11.51
16.07
11.51
16.07
11.51
1
Control diet; PB = control diet supplemented with microencapsulated blend of organic acids and natural identical flavors; and NPB =
control diet supplemented with the same blend of organic acids and
natural identical flavors without the protective matrix coating the
active ingredients.
2
Protastar, Kalmi Italia, Desenzano del Garda (BS), Italy.
3
Provided (per kg of diet, as-fed basis): vitamin A, 18,000 IU; vitamin D3, 2,400 IU; vitamin E, 98 IU; thiamine, 3 mg; riboflavin, 7.2
mg; pyridoxine, 6 mg; pantothenic acid, 24 mg; biotin, 240 g; ascorbic
acid, 90 mg; menadione, 4.8 mg; niacin, 30 mg; cyanocobalamin, 36
g; folic acid, 1.8 mg; choline chloride, 480 mg; CoCO33Co(OH)2H2O,
480 g; FeCO3, 300 mg; Ca(IO3)2, 1.8 mg; MnO2, 48 mg; CuSO45H2O,
120 mg; Na2SeO3, 120 g; and ZnO, 240 mg.
4
DE according to Whittemore (1980); NE according to Noblet et al.
(1994).
488
Piva et al.
Bacterial Counts
Serial 10-fold dilutions of 1 g of samples from caudal
jejunum and cecum were serially diluted and plated
onto Rogosa agar plates for lactic acid bacteria, and
Violet Red Bile agar (Oxoid Ltd., Basingstoke, Hampshire, UK) plates for coliforms. There were 5 replicates
per dietary treatment. Rogosa agar plates were incubated for 48 h at 39C under anaerobic conditions (H2
with approximately 4 to 10% CO2; BBL GasPak Plus
Anaerobic System Envelopes, BD, Sparks, MD). Violet
Red Bile agar plates were incubated for 24 h at 39C
under aerobic conditions.
Statistical Analyses
Data are reported as means SEM, and the level
of significance was P < 0.05. Sorbic acid and vanillin
concentrations in each gastrointestinal tract of animals
fed PB and NPB were compared by unpaired t-test;
sorbic and vanillin concentrations among gastrointestinal tracts of pigs within the same dietary treatment
were compared by 1-way ANOVA. Ammonia and shortchain fatty acid concentrations, pH, and microbial plate
counts within the same gastrointestinal site from the
3 dietary treatments (control, PB, and NPB) were compared, and significant differences among treatment
means were identified by ANOVA. When treatments
effects were detected, means were separated using
Newman-Keuls test. Data were analyzed using the program GraphPad Prism (GraphPad Software 4.00, San
Diego, CA).
RESULTS
Animal Health Status
No outward clinical conditions were observed during
study by the veterinarian in charge of animal welfare.
As such, no medical interventions or treatments were
performed and no piglets died during the study.
489
490
Piva et al.
Table 2. pH, ammonia, and molar proportions of short chain fatty acids in gastrointestinal tract samples from pigs
fed the experimental diets
Gastrointestinal
tract
Iso-valeric
acid
Valeric
acid
Lactic
acid
Total
short
chain
fatty
acids2
0.01
0.00
0.01
0.005
0.446
ND4
ND
ND
ND
ND
ND
ND
ND
ND
ND
5.23
2.63
2.63
0.742
0.068
0.78
0.69
0.88
0.157
0.734
0.14b
0.06a
0.01a
0.019
0.001
ND
0.02
0.01
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
7.33b
4.88ab
3.42a
0.792
0.021
1.37
2.00
1.84
0.283
0.417
ND
0.00
0.01
0.007
0.457
0.10
0.08
0.05
0.022
0.352
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
12.58b
15.04b
3.07a
2.420
0.019
1.76
2.27
3.22
0.518
0.279
1.12a
0.98a
6.31b
0.324
0.001
0.01
0.01
0.04
0.017
0.325
0.04
0.04
0.05
0.006
0.764
0.01a
0.01a
0.26b
0.057
0.014
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
7.20
8.36
4.12
1.177
0.066
1.24
0.98
4.96
0.820
0.040
26.25
28.08
21.69
4.733
0.629
9.94
12.39
13.87
1.659
0.278
5.90
7.06
6.83
0.898
0.634
0.03
0.05
0.02
0.016
0.499
2.43
3.66
3.55
0.471
0.166
0.02
0.03
0.03
0.007
0.537
0.35a
0.65b
0.25a
0.083
0.022
0.64b
0.36ab
0.15a
0.057
0.007
17.12
23.85
24.11
2.956
0.274
1.28
3.32
3.95
1.252
0.380
24.80b
13.61a
12.41a
2.698
0.033
13.72b
7.32a
6.08a
1.648
0.015
0.21b
0.09a
0.08a
0.016
0.001
5.62
3.90
3.55
0.640
0.089
0.15b
0.05a
0.05a
0.007
0.001
1.01c
0.61b
0.26a
0.065
0.001
0.22b
0.07ab
0.05a
0.024
0.012
45.71b
25.58ab
20.07a
4.735
0.018
pH
Ammonia
Acetic
acid
Propionic
acid
Iso-butyric
acid
Control
PB
NPB
3.61
3.48
3.66
0.146
0.673
20.70
16.33
15.97
2.719
0.419
0.68
0.65
0.84
0.139
0.917
0.01
0.00
0.00
0.003
0.345
0.08b
0.03a
0.01a
0.013
0.010
Control
PB
NPB
4.97
5.15
5.34
0.257
0.320
34.57
36.04
35.90
7.301
0.988
1.23
2.01
1.72
0.262
0.213
ND
ND
0.01
0.001
0.001
Control
PB
NPB
5.31a
5.31a
6.10b
0.195
0.022
35.59
41.81
32.52
3.935
0.274
1.74
2.19
3.36
0.476
0.101
Control
PB
NPB
5.44
5.09
6.07
0.310
0.326
52.98
50.96
54.14
4.741
0.893
Control
PB
NPB
5.50
5.47
5.27
0.066
0.060
Control
PB
NPB
5.55
5.63
5.51
0.085
0.596
Treatment1
n-butyric
acid
mol/g of DM
Stomach3
Pooled SEM
P of the model, <
Cranial jejunum
Pooled SEM
P of the model, <
Caudal jejunum
Pooled SEM
P of the model, <
Ileum
Pooled SEM
P of the model, <
Cecum
Pooled SEM
P of the model, <
Colon
Pooled SEM
P of the model, <
Within a column, means without a common superscript letter differ (P < 0.05).
Control diet; PB = control diet supplemented with microencapsulated blend of organic acids and natural identical flavors; and NPB =
control diet supplemented with the same blend of organic acids and natural identical flavors with the protective matrix powder but not coating
the active ingredients.
2
Total short chain fatty acids not including lactic acid.
3
Data are shown as means (n = 5).
4
ND indicates not detectable.
ac
1
DISCUSSION
The ban on antibiotics as growth promoters in the
European Union has forced careful consideration of the
fragile equilibrium between the intestinal microbial
balance and the fermentability of indigestible feed fractions. As quality and availability of feed raw materials
fluctuate, it has become necessary to investigate alternative methods to modulate the intestinal flora beyond
the stomach barrier.
Factors that can affect intestinal microbiota include
OA (Partanen and Mroz, 1999), NIF (Penalver et al.,
491
492
Piva et al.
LITERATURE CITED
Baggot, J. D. 1977. Principles of Drug Disposition in Domestic Animals: The Basis of Veterinary Clinical Pharmacology. Saunders,
Philadelphia, PA.
Boudry, G., V. Peron, I. Le Huerou-Luron, J. P. Lalles, and B. Seve.
2004. Weaning induces both transient and long-lasting modifications of absorptive, secretory, and barrier properties of piglet
intestine. J. Nutr. 134:22562262.
Boyle, W. 1955. Spices and essential oils as preservatives. Am. Perfumer Essential Oil Rev. 66:2528.
Brul, S., and P. Coote. 1999. Preservative agents in food. Mode of
action and antimicrobial resistance mechanisms. Int. J. Food
Microbiol. 50:117.
Burt, S. 2004. Essential oils: Their antibacterial properties and potential applications in foodA review. Int. J. Food Microbiol.
94:223253.
Burt, S. A., R. Vlielander, H. P. Haagsman, and E. J. A. Veldhuizen.
2005. Increase in activity of essential oil components carvacrol
and thymol against Escherichia coli O157:H7 by addition of food
stabilizers. J. Food Prot. 68:919926.
Canibe, N., O. Hojberg, S. Hjsgaard, and B. B. Jensen. 2005. Feed
physical form and formic acid addition to the feed affect the
gastrointestinal ecology and growth performance of growing
pigs. J. Anim. Sci. 83:12871302.
Cosentino, S., C. I. G. Tuberoso, B. Pisano, M. Satta, V. Mascia, E.
Arzedi, and F. Palmas. 1999. In vitro antimicrobial activity and
chemical composition of Sardinian Thymus essential oils. Lett.
Appl. Microbiol. 29:130135.
Falcone, P., B. Speranza, M. A. Del Nobile, M. R. Corbo, and M.
Sinigaglia. 2005. A study on the antimicrobial activity of thymol
intended as a natural preservative. J. Food Prot. 68:16641670.
FDA. 2006. Food and drugs, 21CFR582. http://www.access.gpo.gov/
cgi-bin/cfrassemble.cgi?title=200221 Accessed Jul. 24, 2006.
Frank, K. 1994. Measures to preserve food and feeds from bacterial
damage. UE bersichten zur Tiererna Ehrung 22:149163.
Fussel, R. J., and D. V. McCailey. 1987. Determination of volatile fatty
acids (C2C5) and lactic acid in silage by gas-chromatography.
Analyst 112:12131216.
Gibson, G. R. 1998. Dietary modulation of the human gut microflora
using prebiotics. Br. J. Nutr. 80(Suppl. 2):209212.
Guenther, E. 1948. The Essential Oils. D. Van Nostrand, New
York, NY.
Kim, S. W., D. A. Knabe, K. J. Hong, and R. A. Easter. 2003. Use of
carbohydrases in corn soybean meal-based nursery diets. J.
Anim. Sci. 81:24962504.
Klaenhammer, T. R. 2000. Probiotic bacteria: Today and tomorrow.
J. Nutr. 130:415416.
Kyriakis, S. C. 1989. New aspects of the prevention and/or treatment
of the major stress induced diseases of the early weaned piglet.
Pig News Inf. 2:177181.
Lueck, E. 1980. Antimicrobial Food Additives: Characteristics, Uses,
Effects. Springer-Verlag, Berlin, Germany.
Melin, L., and P. Wallgren. 2002. Aspects on feed related prophylactic
measures aiming to prevent post weaning diarrhoea in pigs.
Acta Vet. Scand. 43:231245.
Noblet, J., H. Fortune, X. S. Shi, and S. Dubois. 1994. Prediction of
net energy value of feeds for growing pigs. J. Anim. Sci. 72(Suppl.
2):344354.
Noel, R. J. 2000. Official feed terms. Pages 187200 in Official Publication. Assoc. Am. Feed Control Officials Inc., West Lafayette, IN.
Partanen, K. H., and Z. Mroz. 1999. Organic acids for performance
enhancement in pig diets. Nutr. Res. Rev. 12:117145.
493